MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
989.70%
Quick Ratio
989.70%
Cash Ratio
150.95%
Debt to Asset Ratio
22.62%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
24,883
22,190
45,445
93,732
Short-term investments
133,218
148,702
145,499
148,065
Prepaid expenses and other current assets (note 5)
4,135
3,132
4,464
3,791
Property and equipment held for sale (note 4)
906
906
1,040
-
Total current assets
163,142
174,930
196,448
245,588
Property and equipment, net (note 4)
2,414
2,664
2,940
4,344
Operating lease right-of-use assets (note 15)
22,289
23,131
23,966
24,794
Restricted cash
1,482
1,482
1,482
1,482
Other non-current assets
554
389
392
392
Total assets
189,881
202,596
225,228
276,600
Accounts payable
1,531
362
480
485
Accrued research and development
9,028
4,141
4,804
7,779
Accrued liabilities (note 6)
3,653
4,143
9,634
8,173
Operating lease liabilities, current (note 15)
2,272
1,713
1,447
1,187
Total current liabilities
16,484
10,359
16,365
17,624
Operating lease liabilities, non-current (note 15)
26,471
27,071
27,658
28,231
Long-term debt (note 7)
0
0
0
30,439
Total liabilities
42,955
37,430
44,023
76,294
Common stock, 0.0001 par value per share 300,000,000 shares authorized at june 30, 2026 and december 31, 2025 and 61,920,154 and 61,449,290 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively (note 9)
6
6
6
6
Additional paid-in capital
1,049,124
1,044,937
1,040,610
1,036,085
Accumulated deficit
-901,807
-879,436
-859,396
-835,819
Accumulated other comprehensive loss
-397
-341
-15
34
Total stockholders equity
146,926
165,166
181,205
200,306
Total liabilities and stockholders equity
189,881
202,596
225,228
276,600
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$133,218K (-24.33%↓ Y/Y)Cash and cashequivalents$24,883K (-71.34%↓ Y/Y)Prepaid expenses andother current assets...$4,135K (-9.54%↓ Y/Y)Property and equipmentheld for sale (note 4)$906K Total current assets$163,142K (-39.00%↓ Y/Y)Operating leaseright-of-use assets (note 15)$22,289K (-12.98%↓ Y/Y)Property and equipment,net (note 4)$2,414K (-50.65%↓ Y/Y)Restricted cash$1,482K (0.00%↑ Y/Y)Other non-currentassets$554K (41.69%↑ Y/Y)Total assets$189,881K (-36.67%↓ Y/Y)Total liabilities andstockholders equity$189,881K (-36.67%↓ Y/Y)Total stockholdersequity$146,926K (-33.24%↓ Y/Y)Total liabilities$42,955K (-46.13%↓ Y/Y)Accumulated deficit-$901,807K (-11.40%↓ Y/Y)Accumulated othercomprehensive loss-$397K (-39600.00%↓ Y/Y)Additional paid-in capital$1,049,124K (1.90%↑ Y/Y)Operating leaseliabilities, non-current...$26,471K (-8.06%↓ Y/Y)Total currentliabilities$16,484K (-19.95%↓ Y/Y)Common stock, 0.0001par value per share...$6K (0.00%↑ Y/Y)Accrued research anddevelopment$9,028K (-16.33%↓ Y/Y)Accrued liabilities(note 6)$3,653K (-49.21%↓ Y/Y)Operating leaseliabilities, current (note...$2,272K (85.47%↑ Y/Y)Accounts payable$1,531K (10.62%↑ Y/Y)

PLIANT THERAPEUTICS, INC. (PLRX)

PLIANT THERAPEUTICS, INC. (PLRX)